These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4716670)
21. Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients? Vaithianathan R J Health Serv Res Policy; 2006 Oct; 11(4):235-9. PubMed ID: 17018198 [TBL] [Abstract][Full Text] [Related]
22. Sleeping pills, insomnia and medical practice. Solomon F; White CC; Parron DL; Mendelson WB N Engl J Med; 1979 Apr; 300(14):803-8. PubMed ID: 34097 [No Abstract] [Full Text] [Related]
23. Narcotics and drug abuse: the federal response. Walsh J Science; 1968 Dec; 162(3859):1254-8. PubMed ID: 5748986 [No Abstract] [Full Text] [Related]
24. Drug abuse--American dilemma. Head M J Kans Med Soc; 1973 Jan; 74(1):9-11. PubMed ID: 4682783 [No Abstract] [Full Text] [Related]
26. Review of literature on the factors affecting drug prescribing. Hemminki E Soc Sci Med (1967); 1975 Feb; 9(2):111-6. PubMed ID: 1093256 [No Abstract] [Full Text] [Related]
27. Abuse of benzodiazepines: the problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc. Am J Drug Alcohol Abuse; 1988; 14 Suppl 1():1-69. PubMed ID: 2902782 [TBL] [Abstract][Full Text] [Related]
28. The influences of drug companies' advertising programs on physicians. Güldal D; Semin S Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183 [TBL] [Abstract][Full Text] [Related]
29. Drug abuse--the doctor's dilemma. Cole JO South Med J; 1972 Sep; 65(9):1051-7. PubMed ID: 5055519 [No Abstract] [Full Text] [Related]
30. Drug control and the British Health Service. Dunlop DM Ann Intern Med; 1969 Aug; 71(2):237-44. PubMed ID: 4979214 [No Abstract] [Full Text] [Related]
32. Avoiding over-deterrence in managing physicians' relationships with industry. Stell LK Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334 [No Abstract] [Full Text] [Related]
33. Attitudes toward appetite suppressants. A survey of US physicians. Lasagna L JAMA; 1973 Jul; 225(1):44-8. PubMed ID: 4740304 [No Abstract] [Full Text] [Related]
34. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801 [TBL] [Abstract][Full Text] [Related]
35. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications. Kopp SW; Bang HK Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219 [TBL] [Abstract][Full Text] [Related]
36. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
37. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults. Dubljević V Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434 [TBL] [Abstract][Full Text] [Related]
38. Internet experts testify about illegal drug sales. Thompson CA Am J Health Syst Pharm; 2006 Jan; 63(2):108, 110. PubMed ID: 16390923 [No Abstract] [Full Text] [Related]
39. Keeping prescription drugs safe and effective. Bryan PA Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343 [No Abstract] [Full Text] [Related]
40. A perspective on drug abuse. Peterson GC; Wilson MR Mayo Clin Proc; 1971 Jul; 46(7):468-76. PubMed ID: 5105406 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]